Rituxan and Angiogram abnormal - a phase IV clinical study of FDA data

Summary:

Angiogram abnormal is reported only by a few people who take Rituxan.

The phase IV clinical study analyzes which people take Rituxan and have Angiogram abnormal. It is created by eHealthMe based on reports of 59,848 people who have side effects while taking Rituxan from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 28, 2023

59,848 people reported to have side effects when taking Rituxan.
Among them, 3 people (0.01%) have Angiogram abnormal.

What is Rituxan?

Rituxan has active ingredients of rituximab. It is often used in rheumatoid arthritis. eHealthMe is studying from 60,345 Rituxan users for its effectiveness, alternative drugs and more.

What is Angiogram abnormal?

Angiogram abnormal is found to be associated with 439 drugs and 166 conditions by eHealthMe.

Number of Rituxan and Angiogram abnormal reports submitted per year:

Gender of people who have Angiogram abnormal when taking Rituxan *:

female: 0.0 %
male: 100 %

Age of people who have Angiogram abnormal when taking Rituxan *:

Common drugs people take besides Rituxan *:

Vitamin C: 2 people, 66.67%
Eliquis: 2 people, 66.67%
Vitamin E: 1 person, 33.33%
Advil: 1 person, 33.33%

Common side effects people have besides Angiogram abnormal *:

Weight Increased: 2 people, 66.67%
Peripheral Swelling: 2 people, 66.67%
Pemphigus (any of several acute or chronic skin diseases characterized by groups of itching blisters): 2 people, 66.67%
Joint Pain: 2 people, 66.67%
High Blood Pressure: 2 people, 66.67%
Headache (pain in head): 2 people, 66.67%
Fatigue (feeling of tiredness): 2 people, 66.67%
Dyspnea Exertional: 2 people, 66.67%
Chest Pain: 2 people, 66.67%
Coordination Abnormal (abnormal movement): 1 person, 33.33%

Common conditions people have *:

Pemphigoid (tense blisters on the skin): 2 people, 66.67%

* Approximation only. Some reports may have incomplete information.

Do you take Rituxan and have Angiogram abnormal?

Check whether Angiogram abnormal is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Angiogram abnormal and when was it recovered:

Angiogram abnormal in Rituxan

Expand to all the drugs that have ingredients of rituximab:

Angiogram abnormal and drugs with ingredients of rituximab

Alternative drugs to, pros and cons of Rituxan:

Rituxan (60,345 reports)

Common Rituxan side effects:

Drug ineffective: 19,157 reports
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints): 12,739 reports
Pain: 8,633 reports
Fatigue (feeling of tiredness): 7,704 reports
Joint pain: 7,091 reports
Joint swelling: 6,359 reports
Rashes (redness): 6,336 reports

Browse all side effects of Rituxan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Angiogram abnormal treatments and more:

Angiogram abnormal (158 reports)

COVID vaccines that are related to Angiogram abnormal:

All the drugs that are associated with Angiogram abnormal:

Angiogram abnormal (439 drugs)

All the conditions that are associated with Angiogram abnormal:

Angiogram abnormal (166 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rituximab (the active ingredients of Rituxan) and Rituxan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.